Crossmark

Relationship between clinical features, GEP class, and PRAME expression in uveal melanoma

Crossref DOI link: https://doi.org/10.1007/s00417-019-04335-w

Published Online: 2019-05-07

Published Print: 2019-07

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Schefler, Amy C.

Koca, Emre

Bernicker, Eric H.

Correa, Zelia M.
License Information

Text and Data Mining valid from 2019-05-07
More Information

Article History

Received: 13 November 2018

Revised: 16 April 2019

Accepted: 19 April 2019

First Online: 7 May 2019

Compliance with ethical standards

:

: ACS—Genentech (Consultant, Grant Funding), Regeneron (Grant Funding), Aura Biosciences (Consultant, Grant Funding), Castle Biosciences (Grant Funding—not for this study); EK—none; EHB—Guardant Health (Advisory Board), Abbvie (Advisory Board), Astra Zeneca (Advisory Board); ZMC—Castle Biosciences (Consultant).

: All procedures in this study was in accordance with the ethical standards of the institutional and/or national research committee and with the 1964 Helsinki declaration and its later amendments or comparable ethical standards.

: Informed consent was obtained from all individual participants included in the study.